Skip to content

Hearing · house

At What Cost: Oversight of How the IRA's Price Setting Scheme Means Fewer Cures for Patients

2023-09-20 · 18:00

Source status: Scheduled

Committee

Location

2123, Rayburn House Office Building

Video

Witnesses

  1. John Czwaratacki

    Founder, Survivors for Solutions

  2. Dr. Steve Potts

    Chair of the Drug Development Council, International Cancer Advocacy Network

  3. John Crowley

    Executive Chairman, Amicus Therapeutics, Inc.

  4. Dr. Aaron Kesselheim

    Professor of Medicine, Harvard Medical School

Documents

Source: https://api.congress.gov/v3/committee-meeting/118/house/116389